Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Notes from the PTSC SHM meeting in Chicago - 1/28/2010

Storm,

Thank you very much for your time and effort. I appreciate that.

You say, "A complete list of stockholders is present. 410 million shares. 334 million shares present or 80% of the shares of the company present at meeting."

I find it absolutely astounding that 35-40 people have %80 of the float. That averages about 8.5 million each, yet none qualify as %5 holders for reporting purposes. That means about 15,985 shareholders make up the remaining holders at an average 4,754 shares each.

Very interesting numbers. I am not sure what to make out of it yet.

Again, Thank you,

(I) C. W.

Share
New Message
Please login to post a reply